Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Uploaded on Sep 15, 2011
Susan was diagnosed with Hodgkin's lymphoma in 2007. Despite several rounds of aggressive treatments, the cancer stayed with her. Her treatment options were running out, until a clinical trial of a new drug gave her a fighting chance. Susan and her physician, Dr. Robert Chen, share their clinical trial experience with brentuximab, recently approved by FDA for relapsed lymphoma patients.
ABOUT CITY OF HOPE City of Hope is a leading medical research, treatment and education center dedicated to preventing, treating and curing cancer, diabetes, HIV/AIDS and other life-threatening diseases. Our mission is to quickly turn research ideas into cures that help save patients' lives all over the world. Learn more at http://www.cityofhope.org.